Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions

Acne VulgarisGingivitis and Periodontal DiseasesSaliva CollectionInflammation BiomarkersVitamin A

Trial Locations (1)

Medipol University, Istanbul

All Listed Sponsors

lead

Medipol University

OTHER

NCT06879795 - Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels | Biotech Hunter | Biotech Hunter